SecSonar.com

Insight Molecular Diagnostics Inc. (IMDX)

Insight Molecular Diagnostics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Insight Molecular Diagnostics Inc. (IMDX) is a Medical - Diagnostics & Research company based in US with a market capitalization of $173.1M. Revenue grew 115.6% year-over-year and free cash flow was negative at -$25.4M. This page tracks IMDX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 46 employees · IPO Dec 30, 2015

Valuation

Valuation & price

$6.41 · as of May 17, 2026 · -24.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.48$5.44$2.40Jul 25Dec 25Jul 26Jul 7, 25$3.03Jul 9, 25$2.97Jul 11, 25$2.86Jul 15, 25$2.78Jul 17, 25$2.83Jul 21, 25$3.03Jul 23, 25$3.01Jul 25, 25$2.88Jul 29, 25$2.73Jul 31, 25$2.52Aug 4, 25$2.77Aug 6, 25$2.65Aug 11, 25$2.61Aug 13, 25$2.45Aug 15, 25$2.40Aug 19, 25$2.60Aug 21, 25$2.48Aug 25, 25$2.49Aug 27, 25$2.48Aug 29, 25$2.53Sep 3, 25$2.56Sep 5, 25$2.48Sep 9, 25$2.67Sep 11, 25$3.18Sep 16, 25$3.44Sep 18, 25$3.37Sep 22, 25$3.27Sep 24, 25$3.28Sep 26, 25$3.33Sep 30, 25$3.32Oct 2, 25$3.34Oct 6, 25$3.28Oct 8, 25$3.68Oct 10, 25$3.89Oct 14, 25$4.08Oct 16, 25$4.63Oct 21, 25$6.63Oct 23, 25$6.42Oct 27, 25$6.50Oct 29, 25$5.91Oct 31, 25$6.01Nov 4, 25$6.13Nov 6, 25$6.50Nov 10, 25$6.80Nov 12, 25$8.48Nov 14, 25$7.40Nov 18, 25$6.33Nov 20, 25$6.07Nov 25, 25$6.15Nov 28, 25$6.14Dec 2, 25$5.52Dec 4, 25$5.58Dec 8, 25$4.94Dec 10, 25$5.09Dec 12, 25$5.22Dec 16, 25$5.10Dec 18, 25$5.19Dec 22, 25$5.56Dec 24, 25$5.82Dec 29, 25$6.63Jan 2, 26$7.16Jan 6, 26$7.39Jan 8, 26$7.50Jan 12, 26$7.11Jan 14, 26$6.85Jan 16, 26$6.64Jan 21, 26$6.51Jan 23, 26$6.52Jan 27, 26$6.89Jan 29, 26$6.62Feb 2, 26$6.86Feb 4, 26$6.64Feb 9, 26$7.14Feb 11, 26$5.73Feb 13, 26$5.57Feb 18, 26$5.32Feb 20, 26$5.49Feb 24, 26$5.64Feb 26, 26$5.67Mar 2, 26$4.94Mar 4, 26$5.47Mar 6, 26$5.45Mar 10, 26$5.35Mar 12, 26$4.89Mar 17, 26$4.53Mar 19, 26$3.92Mar 23, 26$4.00Mar 25, 26$4.14Mar 27, 26$3.56Mar 31, 26$3.28Apr 2, 26$3.76Apr 7, 26$3.21Apr 9, 26$3.18Apr 13, 26$3.00Apr 15, 26$3.42Apr 17, 26$3.84Apr 22, 26$3.75Apr 24, 26$3.76Apr 28, 26$4.20Apr 30, 26$4.01May 4, 26$5.23May 6, 26$5.03May 8, 26$5.01May 12, 26$4.98May 14, 26$6.42May 18, 26$6.35May 20, 26$6.19May 22, 26$6.09May 28, 26$6.53Jun 1, 26$6.16Jun 3, 26$6.03Jun 5, 26$5.24Jun 9, 26$5.85Jun 11, 26$5.43Jun 15, 26$5.70Jun 17, 26$5.32Jun 22, 26$5.40Jun 24, 26$5.38Jun 26, 26$5.40Jul 2, 26$5.74
$2.4052-week range$8.48
Loading valuation history…

Fundamentals

Key fundamentals

$173.1M

Market cap

115.6%

Revenue growth (YoY)

4.7%

Gross margin

-$25.4M

Free cash flow (USD)

-$8.1M

Net debt

Net cash position

133.2%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$1.2MFY 2021$2.2MFY 2022$958.0KFY 2023$1.5MFY 2024$1.9MFY 2025$4.1M
$0$4.1M

Free cash flow by year

2016 → 2025

FY 2016$-7.6MFY 2017$-13.5MFY 2018$-11.7MFY 2019$-20.6MFY 2020$-27.2MFY 2021$-38.2MFY 2022$-49.9MFY 2023$-23.6MFY 2024$-21.2MFY 2025$-25.4M
-$7.6M-$25.4M

Gross margin by year

2021 → 2025

FY 202164.6%FY 2022-1.9%FY 202327.5%FY 202439.3%FY 20254.7%
64.6%4.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 17, 2026Filing
  • 8-K eventAgreement AmendmentMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventBylaw AmendmentsApr 30, 2026Filing

Questions

Frequently asked questions

What is Insight Molecular Diagnostics Inc.'s market cap?

Insight Molecular Diagnostics Inc. (IMDX) has a market capitalization of $173.1M.

What is IMDX's P/E ratio?

A meaningful P/E ratio is not available for IMDX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying IMDX stock?

SEC Form 4 filings show no open-market insider buys at Insight Molecular Diagnostics Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

BDSX

Biodesix, Inc.

$129.6M

ATLN

Atlantic International Corp.

$122.2M

XGN

Exagen Inc.

$119.6M

STIM

Neuronetics, Inc.

$104.4M

SERA

Sera Prognostics, Inc.

$85.5M

NEO

NeoGenomics, Inc.

$276.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.